Testing for fragile X gene mutations throughout the life span.
作者信息
Hagerman Randi J, Hagerman Paul J
机构信息
M.I.N.D. Institute, and Department of Pediatrics, School of Medicine, University of California, Davis, USA.
出版信息
JAMA. 2008 Nov 26;300(20):2419-21. doi: 10.1001/jama.2008.684.
Abstract
摘要
相似文献
1
Testing for fragile X gene mutations throughout the life span.
JAMA. 2008 Nov 26;300(20):2419-21. doi: 10.1001/jama.2008.684.
2
Biomedical research. Fragile X's unwelcome relative.
Science. 2006 Apr 28;312(5773):518-21. doi: 10.1126/science.312.5773.518.
3
Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.
J Dev Behav Pediatr. 2006 Feb;27(1):63-74. doi: 10.1097/00004703-200602000-00012.
4
Methylation analysis of fragile X-related epigenetic elements may provide a suitable newborn screening test for fragile X syndrome.
Genet Med. 2010 Sep;12(9):595. doi: 10.1097/GIM.0b013e3181f07088.
5
Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
Genet Med. 2013 Apr;15(4):290-8. doi: 10.1038/gim.2012.134. Epub 2012 Oct 11.
6
FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia.
Vojnosanit Pregl. 2016 Dec;73(12):1089-93. doi: 10.2298/VSP161006315B.
7
Newborn, carrier, and early childhood screening recommendations for fragile X.
Pediatrics. 2012 Dec;130(6):1126-35. doi: 10.1542/peds.2012-0693. Epub 2012 Nov 5.
8
Genetic defects behind fragile X-related disorders more common: researchers find the incidence of one type of FMR1 allele double its previous estimate in males.
Am J Med Genet A. 2013 Apr;161A(4):x-xi. doi: 10.1002/ajmg.a.35948.
9
Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System.
J Mol Diagn. 2020 Mar;22(3):346-354. doi: 10.1016/j.jmoldx.2019.11.002. Epub 2019 Dec 19.
10
Molecular analysis of alleles for fragile X syndrome diagnosis and patient stratification.
Expert Rev Mol Diagn. 2020 Apr;20(4):363-365. doi: 10.1080/14737159.2020.1729744. Epub 2020 Feb 18.
引用本文的文献
1
Mosaic H3K9me3 at BREACHes predicts synaptic gene expression associated with fragile X syndrome cognitive severity.
bioRxiv. 2025 Mar 19:2025.03.19.644148. doi: 10.1101/2025.03.19.644148.
2
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.
J Autism Dev Disord. 2024 Nov 23. doi: 10.1007/s10803-024-06634-6.
3
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome.
SAGE Open Med. 2024 Sep 29;12:20503121241282401. doi: 10.1177/20503121241282401. eCollection 2024.
4
Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Model of Fragile X Syndrome.
Int J Mol Sci. 2024 Aug 13;25(16):8787. doi: 10.3390/ijms25168787.
5
Neurological, Psychiatric, and Multisystemic Involvement of Fragile X Syndrome Along With Its Pathophysiology, Methods of Screening, and Current Treatment Modalities.
Cureus. 2023 Feb 26;15(2):e35505. doi: 10.7759/cureus.35505. eCollection 2023 Feb.
6
as a Model to Study Fragile X-Associated Disorders.
Genes (Basel). 2022 Dec 28;14(1):87. doi: 10.3390/genes14010087.
7
Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.
J Autism Dev Disord. 2024 Feb;54(2):725-737. doi: 10.1007/s10803-022-05821-7. Epub 2022 Nov 28.
8
Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.
J Neurol. 2022 Sep;269(9):4676-4683. doi: 10.1007/s00415-022-11209-5. Epub 2022 Jun 20.
9
Fragile X Syndrome: From Molecular Aspect to Clinical Treatment.
Int J Mol Sci. 2022 Feb 9;23(4):1935. doi: 10.3390/ijms23041935.
10
Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort.
Am J Med Genet A. 2022 Apr;188(4):1029-1039. doi: 10.1002/ajmg.a.62601. Epub 2021 Dec 10.
本文引用的文献
1
Advances in the treatment of fragile X syndrome.
Pediatrics. 2009 Jan;123(1):378-90. doi: 10.1542/peds.2008-0317.
2
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.
Clin Interv Aging. 2008;3(2):251-62. doi: 10.2147/cia.s1794.
3
Mood and anxiety disorders in females with the FMR1 premutation.
Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):130-9. doi: 10.1002/ajmg.b.30786.
4
Expanded clinical phenotype of women with the FMR1 premutation.
Am J Med Genet A. 2008 Apr 15;146A(8):1009-16. doi: 10.1002/ajmg.a.32060.
5
A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.
J Mol Diagn. 2008 Jan;10(1):43-9. doi: 10.2353/jmoldx.2008.070073. Epub 2007 Dec 28.
6
Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.
J Urol. 2007 Apr;177(4):1434-7. doi: 10.1016/j.juro.2006.11.097.
7
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X.
Neurosci Biobehav Rev. 2007;31(3):315-26. doi: 10.1016/j.neubiorev.2006.09.007. Epub 2006 Nov 9.
8
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.
J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S137-44. doi: 10.1097/00004703-200604002-00012.
9
Protein composition of the intranuclear inclusions of FXTAS.
Brain. 2006 Jan;129(Pt 1):256-71. doi: 10.1093/brain/awh650. Epub 2005 Oct 24.
10
Therapeutic implications of the mGluR theory of fragile X mental retardation.
Genes Brain Behav. 2005 Aug;4(6):393-8. doi: 10.1111/j.1601-183X.2005.00135.x.
Zotero 插件